Skip to main content

NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Contact Details

Matt Riley - Head of Investor Relations & Corporate Communications

mriley@agiletherapeutics.com

Company Website

https://agiletherapeutics.com/

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  252.40
-4.57 (-1.78%)
AAPL  315.34
-0.88 (-0.28%)
AMD  521.10
+15.36 (3.04%)
BAC  62.67
+0.28 (0.45%)
GOOG  328.38
-7.00 (-2.09%)
META  653.69
+40.21 (6.55%)
MSFT  491.65
-2.30 (-0.47%)
NVDA  223.67
-2.06 (-0.91%)
ORCL  161.63
-0.89 (-0.55%)
TSLA  367.81
-0.35 (-0.10%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.